This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jul 7;380(9836):25; author reply 26.

doi: 10.1016/S0140-6736(12)61119-2.

Mortality in intracoronary versus intravenous abciximab

PMID: 22770453
DOI: 10.1016/S0140-6736(12)61119-2

Comment

Mortality in intracoronary versus intravenous abciximab

Adam Iddriss. Lancet. 2012.

. 2012 Jul 7;380(9836):25; author reply 26.

doi: 10.1016/S0140-6736(12)61119-2.

Author

PMID: 22770453
DOI: 10.1016/S0140-6736(12)61119-2

No abstract available

PubMed Disclaimer

Comment on

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.
Thiele H, Wöhrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Wiemer M, Kerber S, Kleinertz K, Eitel I, Desch S, Schuler G. Thiele H, et al. Lancet. 2012 Mar 10;379(9819):923-931. doi: 10.1016/S0140-6736(11)61872-2. Epub 2012 Feb 21. Lancet. 2012. PMID: 22357109 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information